Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Leiomyoma × Sodium Chloride × Clear all

Phase

Phase NA 1 Phase 4 1 Phase 3 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 10 Neoplasms 5 Carcinoma, Non-Small-Cell Lung 4 Pain, Postoperative 3 Melanoma 3 Leukemia, Myeloid, Acute 3 Brain Neoplasms 3 Recurrence 2 Ovarian Neoplasms 2 Hemorrhage 2 Chronic Pain 2 Agnosia 2 Vulvodynia 1 Uterine Cervical Neoplasms 1 Stomatitis 1 Stomach Neoplasms 1 Spinal Cord Neoplasms 1 Small Cell Lung Carcinoma 1 Skin Neoplasms 1 Seizures 1 Radiodermatitis 1 Radiation Injuries 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Postoperative Complications 1 Peripheral Nervous System Diseases 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Parathyroid Neoplasms 1 Papillomavirus Infections 1 Pancreatic Neoplasms 1 Pain, Intractable 1

Interventions

vilaprisan 6 ulipristal acetate 6 asoprisnil 6 telapristone acetate 5 relugolix 5 estradiol, norethindrone drug combination 5 linzagolix 4 elagolix 4 Estradiol 4 Norethindrone Acetate 3 Progestins 2 epigallocatechin gallate 1 Uterine Myomectomy 1 Uterine Artery Embolization 1 Tranexamic Acid 1 Tea 1 Sugars 1 Standard of Care 1 Sodium Chloride 1 Saline Solution 1 Misoprostol 1 Mifepristone 1 Megestrol Acetate 1 Medroxyprogesterone Acetate 1 Leuprolide 1 Laparoscopy 1 Iron 1 Hysterectomy 1 Goserelin 1 Gonadotropin-Releasing Hormone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04655144 2026-01-07

Dex-Fib

University of Miami

Phase 3 Completed

42 enrolled 9 charts

Leiomyoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡